NCT05735067View on ClinicalTrials.gov

The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients

Active, not recruitingOBSERVATIONAL
Enrollment

138

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

July 30, 2025

Conditions
Multiple Sclerosis
Interventions
OTHER

Blood sample collection

5 ml of blood samples were withdrawn from RRMS patients

Trial Locations (1)

1053

Nasser Institute for Research and Treatment, Cairo

All Listed Sponsors
lead

German University in Cairo

OTHER